CTC Pancreatic Adenocarcinoma

NCT02335151 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma
Circulating Tumor Cells
Pancreatic Neoplasms

Interventions

DRUG: Desflurane

Sponsor

University of Zurich

Collaborators

[object Object]
[object Object]
[object Object]